000 | 01799 a2200469 4500 | ||
---|---|---|---|
005 | 20250513225415.0 | ||
264 | 0 | _c20010208 | |
008 | 200102s 0 0 eng d | ||
022 | _a0148-396X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBednar, M M | |
245 | 0 | 0 |
_a16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke. _h[electronic resource] |
260 |
_bNeurosurgery _cDec 2000 |
||
300 |
_a1410-8; discussion 1418-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArachidonic Acid _xmetabolism |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 |
_aCell Aggregation _xdrug effects |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyeicosatetraenoic Acids _xpharmacology |
650 | 0 | 4 |
_aIntracranial Embolism and Thrombosis _xcomplications |
650 | 0 | 4 |
_aIntracranial Pressure _xdrug effects |
650 | 0 | 4 |
_aLeukotriene B4 _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 |
_aStroke _xetiology |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xpharmacology |
700 | 1 | _aGross, C E | |
700 | 1 | _aRussell, S R | |
700 | 1 | _aFuller, S P | |
700 | 1 | _aAhern, T P | |
700 | 1 | _aHoward, D B | |
700 | 1 | _aFalck, J R | |
700 | 1 | _aReddy, K M | |
700 | 1 | _aBalazy, M | |
773 | 0 |
_tNeurosurgery _gvol. 47 _gno. 6 _gp. 1410-8; discussion 1418-9 |
|
999 |
_c11067301 _d11067301 |